369 related articles for article (PubMed ID: 25069049)
21. [LAK sensitivity of human pancreas carcinoma cell lines].
Sugiura H
Hokkaido Igaku Zasshi; 1993 Nov; 68(6):921-34. PubMed ID: 7906667
[TBL] [Abstract][Full Text] [Related]
22. Different susceptibility of cervical keratinocytes containing human papillomavirus to cell-mediated cytotoxicity.
Wu R; Coleman N; Stanley M
Chin Med J (Engl); 1996 Nov; 109(11):854-8. PubMed ID: 9275369
[TBL] [Abstract][Full Text] [Related]
23. Clones derived from human natural killer cells are susceptible to lysis by human interleukin-2-activated killer cells.
Fujiwara T; Loudon WG; Grimm EA
Lymphokine Cytokine Res; 1993 Feb; 12(1):45-8. PubMed ID: 8096153
[TBL] [Abstract][Full Text] [Related]
24. Increased ICAM-1 expression in transformed human oral epithelial cells: molecular mechanism and functional role in peripheral blood mononuclear cell adhesion and lymphokine-activated-killer cell cytotoxicity.
Huang GT; Zhang X; Park NH
Int J Oncol; 2000 Sep; 17(3):479-86. PubMed ID: 10938387
[TBL] [Abstract][Full Text] [Related]
25. All-trans retinoic acid inhibits the growth of breast cancer cells by up-regulating ICAM-1 expression.
Baj G; Arnulfo A; Deaglio S; Tibaldi E; Surico N; Malavasi F
J Biol Regul Homeost Agents; 1999; 13(2):115-22. PubMed ID: 10503735
[TBL] [Abstract][Full Text] [Related]
26. Cytokine regulation of cell-to-cell interactions in lymphokine-activated killer cell cytotoxicity in vitro.
Takahashi T; Ishikura H; Iwai K; Takahashi C; Kato H; Tanabe T; Yoshiki T
Cancer Immunol Immunother; 1993; 36(2):76-82. PubMed ID: 8093857
[TBL] [Abstract][Full Text] [Related]
27. Interferon-gamma-induced increased sensitivity of HER2/neu-overexpressing tumor cells to lymphokine-activated killer cell lysis: importance of ICAM-1 in binding and post-binding events.
Fady C; Gardner A; Gera JF; Lichtenstein A
Cancer Immunol Immunother; 1993 Oct; 37(5):329-36. PubMed ID: 8104695
[TBL] [Abstract][Full Text] [Related]
28. Resistance of HER2/neu-overexpressing tumor targets to lymphokine-activated-killer-cell-mediated lysis: evidence for deficiency of binding and post-binding events.
Fady C; Gardner A; Gera JF; Lichtenstein A
Cancer Immunol Immunother; 1993 May; 36(5):307-14. PubMed ID: 8097427
[TBL] [Abstract][Full Text] [Related]
29. Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.
Ramer R; Merkord J; Rohde H; Hinz B
Biochem Pharmacol; 2010 Apr; 79(7):955-66. PubMed ID: 19914218
[TBL] [Abstract][Full Text] [Related]
30. Heregulin induces increase in sensitivity of an erbB-2-overexpressing breast cancer cell type to lysis by lymphokine-activated killer cells.
Cardillo M; Yankelevich B; Mazumder A; Lupu R
Cancer Immunol Immunother; 1996 Sep; 43(1):19-25. PubMed ID: 8917631
[TBL] [Abstract][Full Text] [Related]
31. Pentoxifylline-induced modulation of melanoma cell growth, adhesion and lymphokine activated killer cell-mediated lysis.
Alexander CL; Edward M; MacKie RM
Melanoma Res; 1999 Feb; 9(1):31-9. PubMed ID: 10338332
[TBL] [Abstract][Full Text] [Related]
32. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
[TBL] [Abstract][Full Text] [Related]
34. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors.
Espejo-Porras F; Fernández-Ruiz J; Pertwee RG; Mechoulam R; García C
Neuropharmacology; 2013 Dec; 75():155-63. PubMed ID: 23924692
[TBL] [Abstract][Full Text] [Related]
35. Reduction of LAK-sensitivity and changes in antigen expression on hepatoma cells by sodium butyrate.
Tada S; Saito H; Ebinuma H; Atsukawa K; Masuda T; Tsunematsu S; Morizane T; Ishii H
Cancer Biochem Biophys; 1996 Apr; 15(3):177-86. PubMed ID: 8937741
[TBL] [Abstract][Full Text] [Related]
36. Expression of the adhesion molecules ICAM-1 and ICAM-2 on tumor cell lines does not correlate with their susceptibility to natural killer cell-mediated cytolysis: evidence for additional ligands for effector cell beta integrins.
Akella R; Hall RE
Eur J Immunol; 1992 Apr; 22(4):1069-74. PubMed ID: 1348028
[TBL] [Abstract][Full Text] [Related]
37. Cytokine modulation of interactions between cultured human renal tubular and lymphoid blast cells.
Takahashi C; Ishikura H; Chikaraishi T; Koyanagi T; Yoshiki T
Pathol Res Pract; 1995 Feb; 191(1):1-7. PubMed ID: 7651927
[TBL] [Abstract][Full Text] [Related]
38. Lymphokine-activated killer (LAK)-mediated lysis of sequentially isolated ovarian cancer cell lines.
Yashar CM; Taylor DD; Gibb RK; Gerçel-Taylor C
Am J Reprod Immunol; 1997 Dec; 38(6):431-7. PubMed ID: 9412727
[TBL] [Abstract][Full Text] [Related]
39. ICAM-1 increases in vitro adhesion and cytotoxicity in a murine fibrosarcoma.
Burno DK; Fabian DF; Lefor AT
J Surg Res; 1996 Feb; 60(2):398-402. PubMed ID: 8598676
[TBL] [Abstract][Full Text] [Related]
40. Efficient generation and characterization of tumor cell subclones with different adhesion pathways involved in cell lysis.
Lefterova P; Negrin R; Neubauer A; Huhn D; Blume K; Schmidt-Wolf I
Haematologica; 1993; 78(6):353-8. PubMed ID: 8175030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
